Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Ernst, Thomas, Chase, Andrew J, Score, Joannah, Hidalgo-Curtis, Claire E, Bryant, Catherine, Jones, Amy V, Waghorn, Katherine, Zoi, Katerina +10 more·2010·Nature Genetics

DOI 10.1038/ng.621

Cited by (1,000)

Items 601–700 of 1,000

CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2
Paula Aranaz, C. Hurtado, Ignacio Erquiaga, Itziar Miguéliz, Cristina Ormazabal, Ion Cristóbal, Marina García‐Delgado, Francisco Javier Novo, J.L. Vizmanos · 2012 · Haematologica
Promises and challenges of anticancer drugs that target the epigenome
Inge Verbrugge, Ricky W. Johnstone, Michael L Bots · 2011 · Epigenomics
Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations
Xavier Cahu, Stefan N. Constantinescu · 2015 · Current Hematologic Malignancy Reports
Myelodysplastic syndrome ( MDS ) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies
Louis Drevon, Alice Marceau‐Renaut, Odile Maarek, Wendy Cuccuini, Emmanuelle Clappier, Virginie Éclache, Thomas Cluzeau, Valentine Richez, Inès Berkaoui, Sophie Dimicoli et al. · 2018 · British Journal of Haematology
Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials
Pan Lai, Yang Wang · 2021 · Cancer Biology and Medicine
Epigenetic Mechanisms in Leukemias and Lymphomas
Cihangir Duy, Wendy Béguelin, Ari M. Melnick · 2020 · Cold Spring Harbor Perspectives in Medicine
Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A–menin to bivalent promoters
Naitao Wang, Mohini R. Pachai, Dan Li, Cindy J. Lee, Sarah Warda, Makhzuna N. Khudoynazarova, Woo Hyun Cho, Guojia Xie, Sagar R Shah, Yao Li et al. · 2025 · Nature Genetics
Epigenetic regulation by ASXL1 in myeloid malignancies
Feng‐Chun Yang, Joel Agosto-Peña · 2023 · International Journal of Hematology
Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
İpek Yönal Hindilerden, Aynur Dağlar Aday, Başak Akadam-Teker, Ceylan Yılmaz, Meliha Nalçacı, Akif Selim Yavuz, Deniz Sargın · 2015 · Journal of Blood Medicine
DNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity
Yanling Wang, Hui Qiang Sun, Jia‐Bin Wang, Huamiao Wang, Lijun Meng, Xu Chen, Mingzhu Jin, Bing Wang, Yu Zhang, Yu Zhang et al. · 2016 · Cell Death and Disease
A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes
Chi‐Yuan Yao, Ching‐Hsuan Chen, Huai‐Hsuan Huang, Hsin‐An Hou, Chien‐Chin Lin, Mei‐Hsuan Tseng, Chein‐Jun Kao, Tzu‐Pin Lu, Wen‐Chien Chou, Hwei‐Fang Tien · 2017 · Blood Advances
Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies
Satoshi Kaito, Atsushi Iwama · 2020 · International Journal of Molecular Sciences
The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population
Junko H. Ohyashiki, Masayuki Yoneta, Hisashi Hisatomi, Tamiko Iwabuchi, Tomohiro Umezu, Kazuma Ohyashiki · 2012 · BMC Medical Genetics
Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis
Richard F. Schlenk, Frank Stegelmann, Andreas Reiter, Edgar Jost, Norbert Gattermann, Holger Frithjof Hebart, Cornelius Florian Waller, Andreas Hochhaus, Uwe Platzbecker, Philippe Schafhausen et al. · 2016 · Leukemia
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post‐ASH symposium
Omar Ibrahim Abdel-Wahab, Animesh Dev Pardanani, Olivier Bernard, Guido Finazzi, John D. Crispino, Heinz Gisslinger, Róbert Královics, Olatoyosi M. Odenike, Kapil N. Bhalla, Vikas K Gupta et al. · 2012 · American Journal of Hematology
Perspectives and future directions for epigenetics in hematology
Margaret A. Goodell, Lucy A. Godley · 2013 · Blood
The significance of CUX1 and chromosome 7 in myeloid malignancies
Matthew R. M. Jotte, Megan E. McNerney · 2021 · Current Opinion in Hematology
Role of Germline Genetic Factors in MPN Pathogenesis
Ashot S. Harutyunyan, Róbert Královics · 2012 · Hematology/Oncology Clinics of North America
Biology of Myeloproliferative Malignancies
Anait Levonovna Melikyan, Irina Nikolaevna Subortseva · 2016 · Clinical oncohematology
Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis
Shaojun Ma, Yanmei Liu, Yuelang Zhang, Mingwei Chen, Wei Cao · 2017 · Bioscience Reports
Precision medicine in Ewing sarcoma: a translational point of view
Pablo Gargallo, A. De Juan, Yania Yáñez, Sandra Dolz, Vanessa Segura, Victoria Castel, Adela Cañete · 2020 · Clinical & Translational Oncology
Novel therapeutic strategies for MLL-rearranged leukemias
Nok-Hei Mickey Wong, Chi Wai Eric So · 2020 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Alterations of Histone Modifications in Cancer
Amir Hosseini, Saverio Minucci · 2018 · Elsevier eBooks
Drug addiction unveils a repressive methylation ceiling in EZH2-mutant lymphoma
Hui Si Kwok, Allyson M. Freedy, Allison P. Siegenfeld, Julia W. Morriss, Amanda L. Waterbury, Stephen M. Kissler, Brian B. Liau · 2023 · Nature Chemical Biology
Histone modification defects in developmental disorders and cancer
Nicholas C.P. Cross · 2012 · Oncotarget
Polycomb and Trithorax Group Proteins: The Long Road from Mutations in Drosophila to Use in Medicine
Darya Chetverina, Д. В. Ломаев, Maksim Erokhin · 2020 · Acta Naturae
Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease
Camilla Bertuzzo Veiga, Erin Lawrence, Andrew James Murphy, Marco J. Herold, Dragana Dragoljevic · 2021 · Cancers
Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor Types
Maksim Erokhin, Olga Chetverina, Balázs Győrffy, Victor Vyacheslavovich Tatarskiy, Vladic Mogila, Alexander Albertovich Shtil, Igor B. Roninson, Jérôme Moreaux, Pavel G Georgiev, Giacomo Cavalli et al. · 2021 · Cancers
Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis
Óscar González‐López, Javier I. Muñoz‐González, Alberto Órfão, Iván Álvarez‐Twöse, Andrés C. García‐Montero · 2022 · Cancers
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology
Yuh Cai Chia, Siti Asmaa Mat Jusoh, Marini Ramli, Peng Yeong Woon, Muhammad Farid Johan, Rosline Hassan, Md Asiful Islam · 2023 · Diagnostics
Enhancer of Zeste Homolog 2 Expression Is Associated With Metastasis and Adverse Clinical Outcome in Clear Cell Renal Cell Carcinoma: A Comparative Study and Review of the Literature
Bin Xu, Samuel R. Abourbih, Kanishka Sircar, Wassim Kassouf, José João Mansure, Armen Garo Aprikian, Simon Tanguay, Fadi Brimo · 2013 · Archives of Pathology & Laboratory Medicine
How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature
Eric Y.L. Wong, Victoria Ling, David Westerman, Susan J. Morgan, Surender K Juneja · 2015 · Journal of Clinical Pathology
Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network
E. Signaroldi, Pasquale Laise, Silvia Cristofanon, Arianna Brancaccio, Elisa Reisoli, Sina Atashpaz, Maria Rosa Terreni, Claudio Doglioni, Giancarlo Pruneri, Paolo Malatesta et al. · 2016 · Nature Communications
Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes
Meagan A. Jacoby, Matthew J. Walter · 2012 · Expert Review of Molecular Diagnostics
Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations
Belinda B. Guo, Richard J. N. Allcock, Bob Mirzai, Jacques A. J. Malherbe, Fizzah Choudry, Mattia Frontini, Hun Sheng Chuah, James Liang, Simon Kavanagh, Rebecca Howman et al. · 2017 · American Journal Of Pathology
Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling
Xuejun Tian, Jie Xu, Christopher D.�M. Fletcher, Jason L. Hornick, David M. Dorfman · 2018 · Modern Pathology
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1
Andres Ernesto Quesada, Guillermo Montalban Bravo, Rajyalakshmi Luthra, Keyur Pravinchandra Patel, Koji Sasaki, Carlos Bueso-Ramos, Joseph David Khoury, Mark J. Routbort, Roland L. Bassett, Juliana E. Hidalgo‐Lόpez et al. · 2020 · Modern Pathology
Polycomb-like Proteins in Gene Regulation and Cancer
Sabrina Fischer, Robert Liefke · 2023 · Genes
GFAP-Cre-Mediated Transgenic Activation of Bmi1 Results in Pituitary Tumors
Bart A. Westerman, Marleen Blom, Ellen Tanger, Martin van der Valk, Ji‐Ying Song, Marije M. van Santen, Jules Gadiot, Paulien Cornelissen‐Steijger, John Zevenhoven, Haydn M. Prosser et al. · 2012 · PLoS ONE
Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Valentina Nardi, Robert Paul Hasserjian · 2016 · Surgical pathology clinics
Mechanisms underlying the heterogeneity of myelodysplastic syndromes
Charles Dussiau, Michaëla Fontenay · 2017 · Experimental Hematology
Anti-cancer Effects of Curcumin on Myelodysplastic Syndrome through the Inhibition of Enhancer of Zeste Homolog-2 (EZH2)
Ling Ma, Xia Zhang, Zhiqiong Wang, Lifang Huang, Fankai Meng, Lihua Hu, Yan Chen, Jia Wei · 2019 · Current Cancer Drug Targets
High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
Huihui Zhang, Ninghan Zhang, Rong Wang, Tingting Shao, Feng Yuan, Yao Yao, Qingyun Wu, Shengyun Zhu, Jiang Cao, Huan-Xin Zhang et al. · 2019 · Journal of Translational Medicine
Epigenetics of paediatric acute myeloid leukaemia
Luke Jones, Peter McCarthy, Jonathan Bond · 2019 · British Journal of Haematology
Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome
Urszula Oleksiewicz, Marta Machnik · 2020 · Seminars in Cancer Biology
Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential
Ly Vu, Luisa Luciani, Stephen D. Nimer · 2013 · International Journal of Hematology
EZH2 is highly expressed in pituitary adenomas and associated with proliferation
David Schult, Annett Hölsken, Sonja Siegel, Michael Buchfelder, Rudolf Fahlbusch, Ilonka Kreitschmann‐Andermahr, Rolf Buslei · 2015 · Scientific Reports
Myelodysplastic Syndromes
Olatoyosi M. Odenike, John Anastasi, Michelle M. Le Beau · 2011 · Clinics in Laboratory Medicine
Biomolecules Interacting with Long Noncoding RNAs
Hidenori Tani · 2025 · Biology
Loss of Pcgf5 Affects Global H2A Monoubiquitination but Not the Function of Hematopoietic Stem and Progenitor Cells
Sha Si, Yaeko Nakajima‐Takagi, Kazumasa Aoyama, Motohiko Oshima, Atsunori Saraya, Hiroki Sugishita, Manabu Nakayama, Tomoyuki Ishikura, Haruhiko Koseki, Atsushi Iwama · 2016 · PLoS ONE
EZH2 W113C is a gain-of-function mutation in B-cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance
Liping Chu, Dongxia Tan, Meimei Zhu, Yu-Xiu Qu, Xin Ma, Bao‐Liang Song, Wei Qi · 2023 · Journal of Biological Chemistry
Dual inhibition of EZH2 and G9A/GLP histone methyltransferases by HKMTI-1-005 promotes differentiation of acute myeloid leukemia cells
Yordan Sbirkov, Tino Schenk, Colin Kwok, Sven Stengel, Robert Eldon Brown, Geoffrey Brown, Louis Chesler, Arthur Zelent, Matthew John Fuchter, Kevin R. Petrie · 2023 · Frontiers in Cell and Developmental Biology
Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms
Laura Calabresi, Chiara Carretta, Simone Romagnoli, Giada Rotunno, Sandra Parenti, Matteo Bertesi, Niccolò Bartalucci, Sebastiano Rontauroli, Chiara Chiereghin, Sara Castellano et al. · 2023 · American Journal of Hematology
Chronic myelomonocytic leukemia: Myelodysplastic or myeloproliferative?
Raphaël Itzykson, Pierre Fenaux, Éric Solary · 2013 · Best Practice & Research Clinical Haematology
Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases
Martin Chopra, Stefan K. Bohlander · 2014 · Cancer Genetics
Detection of leukemia-associated mutations in peripheral blood DNA of hematologically normal elderly individuals
J Score, Andrew Chase, Lars Anders Forsberg, Li Feng, Katherine Waghorn, Amy V. Jones, Chiara Rasi, David C. Linch, Jan Piotr Dumanski, Rosemary E. Gale et al. · 2015 · Leukemia
Epigenetic targeting and personalized approaches for AML
Gail J. Roboz · 2014 · Hematology
Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts
Véronique Gelsi‐Boyer, Nathalie Cervera, François Bertucci, Mandy Brecqueville, Pascal Finetti, Anne Murati, Christine Arnoulet, Julien Mozziconacci, Ken Mills, Nicholas C.P. Cross et al. · 2012 · Haematologica
Down-regulation of EZH2 expression in myelodysplastic syndromes
Mónica Cabrero, Yue Wei, Hui Yang, Irene Gañán‐Gómez, Zach Bohannan, Simona Colla, Matteo Marchesini, Guillermo Montalban Bravo, Koichi Takahashi, Carlos Bueso-Ramos et al. · 2016 · Leukemia Research
Prognosis of Primary Myelofibrosis in the Genomic Era
Prithviraj Bose, Srđan Verstovšek · 2016 · Clinical Lymphoma Myeloma & Leukemia
Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7
Elena Crisà, Austin Gladston Kulasekararaj, Vera Ademà, Esperanza Such, Julie Schanz, Detlef Thomas Haase, Katayoon Shirneshan, Steven Best, Syed A. Mian, Aytug Kizilors et al. · 2020 · Leukemia
THE ROLE OF HMGA2 IN THE PROLIFERATION AND EXPANSION OF A HEMATOPOIETIC CELL IN MYELOPROLIFERATIVE NEOPLASMS
Kazuhiko Ikeda, Kazuei Ogawa, Yasuchika Takeishi · 2012 · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
Clinical Significance of Previously Cryptic Copy Number Alterations and Loss of Heterozygosity in Pediatric Acute Myeloid Leukemia and Myelodysplastic Syndrome Determined Using Combined Array Comparative Genomic Hybridization plus Single-Nucleotide Polymorphism Microarray Analyses
Kyung‐Nam Koh, Jin Ok Lee, Eul‐Ju Seo, Seong Wook Lee, Jin Kyung Suh, Ho Joon Im, Jong Jin Seo · 2014 · Journal of Korean Medical Science
Molecular biology of Philadelphia-negative myeloproliferative neoplasms
Paulo Vidal Campregher, Fábio Pires de Souza Santos, Guilherme Fleury Perini, Nelson Hamerschlak · 2012 · Revista Brasileira de Hematologia e Hemoterapia
Advances in the Management of Myelofibrosis
Rami S. Komrokji, Srđan Verstovšek, Eric Padron, Alan F. List · 2012 · Cancer Control
The study of epigenetic mechanisms based on the analysis of histone modification patterns by flow cytoametry
Maria Watson, Sue Chow, Dalia Barsyte, C.H. Arrowsmith, T. Vincent Shankey, Mark David Minden, David William Hedley · 2013 · Cytometry Part A
New Insights into the Pathogenesis of MDS and the rational therapeutic opportunities
Abdallah Abou Zahr, Carolina Bernabe, Jocelyn L. Wozney, Thomas Prébet, Amer Methqal Zeidan · 2016 · Expert Review of Hematology
Acute myeloid leukemia: novel mutations and their clinical implications.
Harshita Makkar, Ravi Kumar Majhi, Harsh Goel, Aditya Gupta, Anita Chopra, Pranay Tanwar, Rachna Kapoor Seth · 2023 · PubMed Central
Array-Based Cytogenetic Approaches in Acute Myeloid Leukemia: Clinical Impact and Biological Insights
Lars Bullinger, Stefan Fröhling · 2012 · Seminars in Oncology
Clinical and molecular genetic characterization of myelofibrosis
Gabriela Soriano Hobbs, Raajit K. Rampal · 2015 · Current Opinion in Hematology
Immunomodulatory agents in myelofibrosis
Ali Tabarroki, Ramon Velasquez Tiu · 2012 · Expert Opinion on Investigational Drugs
New Strategies in Myelodysplastic Syndromes: Application of Molecular Diagnostics to Clinical Practice
Zuzana Tóthová, David P. Steensma, Benjamin L. Ebert · 2013 · Clinical Cancer Research
Advances in the understanding and management of primary myelofibrosis
Francisco Cervantes, Arturo Pereira · 2011 · Current Opinion in Oncology
The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) – Mechanisms and Opportunities
Kathrin Maria Bernt, Stephen P. Hunger, Tobias Neff · 2016 · Frontiers in Pediatrics
After 10 years of JAK2V617F: Disease biology and current management strategies in polycythaemia vera
Jacob Grinfeld, Anna L. Godfrey · 2016 · Blood Reviews
Safety considerations with targeted therapy drugs for B-cell non-Hodgkin lymphoma
Shinichi Makita, Rika Hosoba, Kensei Tobinai · 2020 · Expert Opinion on Drug Safety
Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
Yotaro Ochi, Seishi Ogawa · 2021 · Cancers
Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view
Karlijn Hasaart, Eline J.M. Bertrums, Freek Manders, Bianca F. Goemans, Ruben van Boxtel · 2021 · Expert Reviews in Molecular Medicine
Dual role of EZH2 in megakaryocyte differentiation
Stefania Mazzi, Philippe Dessen, Mathieu Vieira, Virginie Dufour, Marie Cambot, Mira El-Khoury, Iléana Antony‐Debré, Brahim Arkoun, Francesca Basso‐Valentina, Salwa BenAbdoulahab et al. · 2021 · Blood
Myeloid malignancies with acquired trisomy 21 as the sole cytogenetic change are clinically highly variable and display a heterogeneous pattern of copy number alterations and mutations*
Nina Larsson, Henrik Lilljebjörn, Carin Lassen, Bertil Johansson, Thoas Fioretos · 2011 · European Journal Of Haematology
CD133 marks a stem cell population that drives human primary myelofibrosis
Ioanna Triviai, T. Stubig, Birte Niebuhr, Kais Hussein, Asterios S. Tsiftsoglou, Boris Fehse, Carol Stocking, Nicolaus Martin Kröger · 2015 · Haematologica
Cell Fate Decisions in Malignant Hematopoiesis: Leukemia Phenotype Is Determined by Distinct Functional Domains of the MN1 Oncogene
Courteney K. Lai, Yeonsook Moon, Florian C. Kuchenbauer, Daniel T. Starzcynowski, Bob Argiropoulos, Eric Yung, Philip A. Beer, Adrian Schwarzer, Amit Sharma, Gyeongsin Park et al. · 2014 · PLoS ONE
Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm
Hernando López-Bertoni, Yun-Qing Li, John Laterra · 2015 · Biology and Medicine
The phenotype of EZH2 haploinsufficiency—1.2‐Mb deletion at 7q36.1 in a child with tall stature and intellectual disability
Tanay Suri, Abhijit Dixit · 2017 · American Journal of Medical Genetics Part A
Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas
Xuejun Tian, Jie Xu, David M. Dorfman · 2018 · The American Journal of Surgical Pathology
Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression
Nisha Gautam, Mandeep Kaur, Satbir Kaur · 2020 · Journal of Cancer Research and Therapeutics
Diagnosis and treatment of lymphomas in the era of epigenetics
Alain Chebly, Éliane Chouery, Joana Ropio, Hampig Raphaël Kourié, Marie Beylot-Barry, Jean‐Philippe Merlio, Roland R. Tomb, Edith Chevret · 2020 · Blood Reviews
Genetics, Epigenetics, and Leukemia
Kevin Shannon, Scott A. Armstrong · 2010 · New England Journal of Medicine
Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities
Michał Woźniak, Małgorzata Czyż · 2025 · Therapeutic Advances in Medical Oncology
CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity
Xiao Huo, Hengzi Sun, Qiuhong Qian, Xiangwen Ma, Peng Peng, Mei Yun Yu, Ying Zhang, Jiaxin Yang, Dongyan Cao, Ting Gui et al. · 2020 · Frontiers in Cell and Developmental Biology
Polycomb repressor complex: Its function in human cancer and therapeutic target strategy
Jingrong Liu, Hongjie Fan, Xinmiao Liang, Yang Chen · 2023 · Biomedicine & Pharmacotherapy
A primer on genomic and epigenomic alterations in the myeloproliferative neoplasms
Raajit K. Rampal, Ross L. Levine · 2014 · Best Practice & Research Clinical Haematology
Focus on the epigenome in the myeloproliferative neoplasms
Eun Hee Kim, Omar Ibrahim Abdel-Wahab · 2013 · Hematology
The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL
Paniz Tavakoli Shirazi, Laura N Eadie, Susan L. Heatley, Timothy P. Hughes, David T. O. Yeung, Deborah L. White · 2019 · British Journal of Cancer
Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
Arti Easwar, Alexa J. Siddon · 2021 · Life
Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation
Mengjia Li, Donghao Liu, Fumin Xue, Hengchao Zhang, Qianqian Yang, Lei Sun, Xiaoli Qu, Xiuyun Wu, Huizhi Zhao, Jing Liu et al. · 2023 · Haematologica
New Insights in AML Biology From Genomic Analysis
Ashley Marie Perry, Eyal C. Attar · 2014 · Seminars in Hematology
Leveraging Cancer Genome Information in Hematologic Malignancies
Raajit K. Rampal, Ross L. Levine · 2013 · Journal of Clinical Oncology
The First Case of Decitabine Successfully in Treatment of Atypical Chronic Myeloid Leukemia with CEBPA Double Mutation
Liping Mao Liangshu You · 2013 · Chemotherapy Open access
Genetic basis of myelodysplastic syndromes
Seishi Ogawa · 2020 · Proceedings of the Japan Academy Series B